HARRIS C MARTIN
SEC CIK 1236982 · EDGAR
BoughtSold
Most active insiders at TMO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CASPER MARC N | COB, CEO, Dir | — | $53.89M |
| 2 | Lagarde Michel | EVP, COO | — | $51.31M |
| 3 | Shafer Michael D | EVP | — | $22.54M |
| 4 | Britt Lisa P. | SVP, Chief HR Off | — | $16.87M |
| 5 | Lowery Frederick M. | EVP | — | $8.15M |
| 6 | Pettiti Gianluca | Pres, COO | — | $5.12M |
| 7 | Holmes Joseph R. | VP, CAO | — | $245.6K |
| 8 | Meyer James | CFO, Sr. VP | — | — |
| 9 | Shropshire Thomas B Jr. | SVP, GC | — | — |
| 10 | Keith R. Alexandra | Dir | — | — |
| 18 | HARRIS C MARTIN | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 16:03 | 2026-05-20 | TMO | Thermo Fisher Scientific | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +499 | 9,532 | +6% | $0 | |
| D | 2026-05-13 16:46 | 2026-05-11 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +1,556 | 24.5K | +7% | $0 |
| 2026-05-01 16:15 | 2026-04-29 | CTEV | Claritev Corp | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +8,977 | 24.3K | +59% | $0 | |
| 2025-05-22 | 2025-05-21 | TMO | Thermo Fisher Scientific | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +565 | 9,033 | +7% | $0 | |
| D | 2025-05-14 | 2025-05-12 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +1,514 | 22.8K | +7% | $0 |
| 2025-05-02 | 2025-04-30 | CTEV | Claritev Corp | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +7,356 | 15.3K | +93% | $0 | |
| 2024-05-23 | 2024-05-22 | TMO | Thermo Fisher Scientific | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +339 | 8,468 | +4% | $0 | |
| D | 2024-05-15 | 2024-05-13 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +1,905 | 21.2K | +10% | $0 |
| 2024-04-26 | 2024-04-24 | CTEV | Claritev Corp | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +172.4K | 318.0K | +118% | $0 | |
| D | 2024-02-02 | 2024-01-31 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | M - OptEx | $62.04 | +2,760 | 22.0K | +14% | +$171.2K |
| D | 2024-02-02 | 2024-01-31 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | S - Sale+OE | $84.50 | -2,760 | 19.3K | -13% | -$233.2K |
| 2023-05-26 | 2023-05-24 | TMO | Thermo Fisher Scientific | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +392 | 8,129 | +5% | $0 | |
| D | 2023-05-17 | 2023-05-15 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +2,220 | 19.2K | +13% | $0 |
| 2023-04-28 | 2023-04-26 | CTEV | Claritev Corp | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +106.4K | 145.6K | +271% | $0 | |
| D | 2023-02-23 | 2023-02-21 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | M - OptEx | $71.65 | +5,703 | 22.7K | +34% | +$408.6K |
| D | 2023-02-23 | 2023-02-21 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | S - Sale+OE | $74.25 | -5,703 | 17.0K | -25% | -$423.4K |
| 2022-05-20 | 2022-05-18 | TMO | Thermo Fisher Scientific | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +369 | 7,737 | +5% | $0 | |
| D | 2022-05-11 | 2022-05-09 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +2,317 | 17.0K | +16% | $0 |
| 2022-04-28 | 2022-04-26 | CTEV | Claritev Corp | HARRIS C MARTIN | Dir | A - Grant | $0.00 | +22.3K | 39.2K | +131% | $0 | |
| D | 2022-02-04 | 2022-02-02 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | M - OptEx | $71.76 | +4,491 | 19.1K | +31% | +$322.3K |
| D | 2022-02-04 | 2022-02-02 | CL | Colgate-Palmolive | HARRIS C MARTIN | Dir | S - Sale+OE | $82.76 | -4,491 | 14.7K | -23% | -$371.7K |
Purchase Sale Sale after option exercise All abbreviations